ID   K31M28
AC   CVCL_T838
SY   HPS0074
DR   GEO; GSM1227440
DR   GEO; GSM1227441
DR   RCB; HPS0074
DR   SKIP; SKIP000141
DR   Wikidata; Q54899278
RX   Patent=US10519422;
RX   PubMed=24527394;
CC   Population: Japanese.
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: SKIP; SKIP000141; probable.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C85045; Retinitis pigmentosa
DI   ORDO; Orphanet_791; Retinitis pigmentosa
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60-69Y
CA   Induced pluripotent stem cell
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 15
//
RX   Patent=US10519422;
RA   Takahashi, Masayo
RA   Okamoto, Satoshi
RA   Sakai, Noriko
RT   "Method of producing human retinal pigment epithelial cells.";
RL   Patent number US10519422, 31-Dec-2019.
//
RX   PubMed=24527394; DOI=10.1016/j.stemcr.2013.12.007; PMCID=PMC3923225;
RA   Kamao, Hiroyuki
RA   Mandai, Michiko
RA   Okamoto, Satoshi
RA   Sakai, Noriko
RA   Suga, Akiko
RA   Sugita, Sunao
RA   Kiryu, Junichi
RA   Takahashi, Masayo
RT   "Characterization of human induced pluripotent stem cell-derived
RT   retinal pigment epithelium cell sheets aiming for clinical
RT   application.";
RL   Stem Cell Reports 2:205-218(2014).
//